Evidence map›Paper›PMID 38097317›Full record

Observational studyThe Lancet. Child & adolescent health2024

Paediatric Cushing syndrome: a prospective, multisite, observational cohort study.

Christina Tatsi, Crystal Kamilaris, Meg Keil, Lola Saidkhodjaeva, Fabio R Faucz, Prashant Chittiboina, Constantine A Stratakis

Erratum issuedOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in The Lancet. Child & adolescent health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 7 citations in OpenAlex.

  1. Cushing's disease across the lifespan: a case-based clinical review.Archives of endocrinology and metabolism · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Christina TatsiUnit on Hypothalamic and Pituitary Disorders, National Institutes of Health, Bethesda, MD, USA. Electronic address: christina.tatsi3@nih.gov.
Crystal KamilarisUnit on Hypothalamic and Pituitary Disorders, National Institutes of Health, Bethesda, MD, USA.
Meg KeilOffice of the Clinical Director, National Institutes of Health, Bethesda, MD, USA.
Lola SaidkhodjaevaUnit on Hypothalamic and Pituitary Disorders, National Institutes of Health, Bethesda, MD, USA.
Fabio R FauczMolecular Genomics Core, National Institutes of Health, Bethesda, MD, USA.
Prashant ChittiboinaEunice Kennedy Shriver National Institute of Child Health and Human Development, and Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Constantine A StratakisUnit on Hypothalamic and Pituitary Disorders, National Institutes of Health, Bethesda, MD, USA; Human Genetics & Precision Medicine, Foundation for Research & Technology Hellas, Heraklion, Greece.
National Institutes of Health · USEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

Evaluation of Hypothalamic and Pituitary DisordersZIAHD009017 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI TATSI, CHRISTINA · 2022 to 2025
$3.8M
Intramural NIH HHS ZIA HD009017
6 · The paper itself

Abstract

backgroundPaediatric endogenous Cushing syndrome is a rare condition with variable signs and symptoms of presentation. We studied a large cohort of paediatric patients with endogenous Cushing syndrome with the aim of describing anthropometric, clinical, and biochemical characteristics as well as associated complications and outcomes to aid diagnosis, treatment, and management.

methodsIn this prospective, multisite cohort study, we studied children and adolescents (≤18 years at time of presentation) with a diagnosis of Cushing syndrome. Patients had either received their initial diagnosis and evaluation at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Bethesda, MD, USA) or been referred from other centres in the USA or outside the USA. We collected participants' clinical, biochemical, and imaging findings and recorded their post-operative course until their latest appointment.

findingsOf 342 paediatric patients with a diagnosis of Cushing syndrome, 193 (56%) were female and 149 (44%) male. 261 (76%) patients had corticotroph pituitary neuroendocrine tumours (Cushing disease), 74 (22%) had adrenal-associated Cushing syndrome, and seven (2%) had ectopic Cushing syndrome. Patients were diagnosed at a median of 2 years (IQR 1·0-3·0) after the first concerning sign or symptom, and patients with adrenal-associated Cushing syndrome were the youngest at diagnosis (median 10·4 years [IQR 7·4-13·6] vs 13·0 years [10·5-15·3] for Cushing disease vs 13·4 years [11·0-13·7] for ectopic Cushing syndrome; p<0·0001). Body-mass index z-scores did not differ between the diagnostic groups (1·90 [1·19-2·34] for adrenal-associated Cushing syndrome vs 2·18 [1·60-2·56] for Cushing disease vs 2·22 [1·42-2·35] for ectopic Cushing syndrome; p=0·26). Baseline biochemical screening for cortisol and adrenocorticotropin at diagnosis showed overlapping results between subtypes, and especially between Cushing disease and ectopic Cushing syndrome. However, patients with ectopic Cushing syndrome had higher urinary free cortisol (fold change in median cortisol concentration from upper limit of normal: 15·5 [IQR 12·7-18·0]) than patients with adrenal-associated Cushing syndrome (1·5 [0·6-5·7]) or Cushing disease (3·9 [2·3-6·9]; p<0·0001). Common complications of endogenous Cushing syndrome were hypertension (147 [52%] of 281 patients), hyperglycaemia (78 [30%] of 260 patients), elevated alanine transaminase (145 [64%] of 227 patients), and dyslipidaemia (105 [48%] of 219 patients). Long-term recurrence was noted in at least 16 (8%) of 195 patients with Cushing disease.

interpretationThis extensive description of a unique cohort of paediatric patients with Cushing syndrome has the potential to inform diagnostic workup, preventative actions, and follow-up of children with this rare endocrine condition.

fundingIntramural Research Program, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health.

Indexed as

Cushing SyndromePituitary ACTH HypersecretionAdolescentChildCohort StudiesFemaleHumansHydrocortisoneMaleProspective StudiesHydrocortisone

Identifiers

PMID38097317
PMCPMC11245730
OpenAlexW4389637898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.